Figure 6.
Expressions of Arg-1, NF-κB p65, p-NF-κB p65, MAPK, p-MAPK, and AKT in subcutaneous tumors from mice treated with radioimmunotherapy or triple therapy. RT: radiotherapy; IO: immunotherapy; AN: anlotinib.
Expressions of Arg-1, NF-κB p65, p-NF-κB p65, MAPK, p-MAPK, and AKT in subcutaneous tumors from mice treated with radioimmunotherapy or triple therapy. RT: radiotherapy; IO: immunotherapy; AN: anlotinib.